This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI) (PROMISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03986138
Recruitment Status : Completed
First Posted : June 14, 2019
Last Update Posted : November 10, 2021
Information provided by (Responsible Party):

Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the Results Quality Control (QC) review process. Results information is submitted to by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status : Completed
Actual Primary Completion Date : December 9, 2020
Actual Study Completion Date : December 9, 2020
Certification/Extension First Submitted : May 12, 2021
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 24, 2022
November 17, 2022 Submission with QC Comments
2 September 7, 2023
September 27, 2023 Submission with QC Comments
3 November 7, 2023
November 28, 2023 Submission with QC Comments